MAPT and Alzheimer disease: Initiation of tau hyperphosphorylation is not well-understood but defining the molecular mechanisms of initial hyperphosphorylation induction and propagation of tauopathy through the brain is paramount to slowing or stopping the spread of pathological tau and identifying new candidates for effective AD therapeutics.